Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Devax Inc.
BioStar Could Light Path For Device Investors
BioStar Ventures, founded by physicians who are leaders in the interventional cardiology field, is demonstrating how medical device investors might benefit with close ties to clinical and corporate worlds.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Deals Shaping the Medical Industry (12/2010)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
Cappella: Can a New Twist On An Old Idea Solve the Bifurcation Challenge?
Device companies large and small have failed repeatedly in efforts to address bifurcations, which remain one of the largest unmet opportunities in cardiology. Cappella thinks it can solve the problem with a device that's a new version of an old idea, reversing current protocol to treat the side branch first.
- Drug Delivery
- Implantable Devices
- Surgical Equipment & Devices
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.